Literature DB >> 10987261

Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

C Basso1, G Thiene, D Corrado, G Buja, P Melacini, A Nava.   

Abstract

The mechanism underlying cardiac arrest in patients with hypertrophic cardiomyopathy (HC) is intriguing. In the clinical setting, myocardial ischemia has long been incriminated, particularly in the young. Among 274 cardiovascular sudden deaths in the young (< or = 35 years), 19 (7.0%), 14 males and 5 females, median age 23 years, had HC. Familial occurrence of HC was ascertained in 3 (16%). SD occurred on effort in 6 (31%). Previous syncope occurred in 5 and palpitations in 3. Basal electrocardiogram (ECG) was abnormal in 7 of 8 available cases. Hypertrophy was septal asymmetric in 14. Gross examination showed large isolated or multiple septal scars in 11 (58%); at histomorphometry, the mean percent area of fibrosis of the septal myocardium was 18.6 +/- 6. Four showed a deep intramyocardial course of the left anterior descending coronary artery. At histology, myocardial disarray involved 30 +/- 16% of the septal myocardium; evidence of acute-subacute myocardial necrosis was present in 14 (74%), 1 of them with a regional acute myocardial infarction. By comparing hearts with (n = 11) and without (n = 8) areas of scar-type fibrosis, we found a statistically significant difference in terms of age (25.5 +/- 5.4 v 15.5 +/- 12.4 years, P = .04), septal thickness (25.4 +/- 5.4 v 15.4 +/- 4.9 mm, P < .001), percent increase of septal thickness versus normal value for age and sex (46.2 +/- 15 v 25.2 +/- 13.6%, P < .01) and mean score of small vessel disease (1.7 +/- 0.4 v 1.2 +/- 0.4, P = .04). Linear regression analysis showed a positive correlation of percent area of replacement fibrosis with septal thickness (P = .01) and with mean score of small vessel disease (P < .01). In conclusion, our pathologic findings of ischemic damage, either acute-subacute or in the form of fibrotic scars, support the clinical evidence that ischemia occurs in the natural history of HC and may contribute to life-threatening electrical instability.

Entities:  

Mesh:

Year:  2000        PMID: 10987261     DOI: 10.1053/hupa.2000.16659

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  89 in total

Review 1.  Utility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease.

Authors:  M Francone; I Carbone; L Agati; C Bucciarelli Ducci; M Mangia; I Iacucci; C Catalano; R Passariello
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

2.  Detection of repolarization abnormalities in patients with cardiomyopathy using current vector mapping technique on magnetocardiogram.

Authors:  Junko Shiono; Hitoshi Horigome; Akira Matsui; Yasushi Terada; Tsuyoshi Miyashita; Keiji Tsukada
Journal:  Int J Cardiovasc Imaging       Date:  2003-04       Impact factor: 2.357

Review 3.  Nuclear cardiac imaging in hypertrophic cardiomyopathy.

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

Review 4.  Mandatory ECG screening of athletes: is this question now resolved?

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2011-12-01       Impact factor: 11.136

5.  Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study.

Authors:  Paul Knaapen; Willem G van Dockum; Marco J W Götte; Kimiko A Broeze; Joost P A Kuijer; Jaco J M Zwanenburg; J Tim Marcus; Wouter E M Kok; Albert C van Rossum; Adriaan A Lammertsma; Frans C Visser
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952

6.  Editorial. Hypertrophic Cardiomyopathy with ventricular tachycardia.

Authors:  Deborah H Kwon; Milind Y Desai
Journal:  Int J Cardiovasc Imaging       Date:  2007-06-01       Impact factor: 2.357

Review 7.  Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease.

Authors:  Ardan M Saguner; Corinna Brunckhorst; Firat Duru
Journal:  World J Cardiol       Date:  2014-04-26

8.  High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy.

Authors:  Yasuki Hen; Nobuo Iguchi; Haruhiko Machida; Kaori Takada; Yuko Utanohara; Tetsuya Sumiyoshi
Journal:  Heart Vessels       Date:  2012-10-25       Impact factor: 2.037

9.  Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study.

Authors:  Deborah H Kwon; Randolph M Setser; Zoran B Popović; Maran Thamilarasan; Srikanth Sola; Paul Schoenhagen; Mario J Garcia; Scott D Flamm; Harry M Lever; Milind Y Desai
Journal:  Int J Cardiovasc Imaging       Date:  2008-01-19       Impact factor: 2.357

10.  Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.

Authors:  Da-Jun Hu; Jing Xu; Wei Du; Jian-Xin Zhang; Min Zhong; Ya-Nan Zhou
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-26       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.